Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes - Bethel, M. A.; Harrison, P.; Sourij, H.; Sun, Y.; Tucker, L.; Kennedy, I.; White, S.; Hill, L.; Oulhaj, A.; Coleman, R. L.; Holman, R. R. (Diabetic medicine, 2016)
Keywords: Adult; Aspirin - administration & dosage; Aspirin - adverse effects; Aspirin - therapeutic use; Cardiovascular Diseases - complications; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - prevention & control; Cross-Over Studies; Cyclooxygenase Inhibitors - administration & dosage; Cyclooxygenase Inhibitors - adverse effects; Cyclooxygenase Inhibitors - therapeutic use; Diabetes; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - complications; Diabetic Angiopathies - epidemiology; Diabetic Angiopathies - prevention & control; Diabetic Cardiomyopathies - epidemiology; Diabetic Cardiomyopathies - prevention & control; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; England - epidemiology; Female; Hemorrhage - chemically induced; Hemorrhage - complications; Hemorrhage - epidemiology; Humans; Male; Middle Aged; Platelet Activation - drug effects; Platelet Aggregation Inhibitors - administration & dosage; Platelet Aggregation Inhibitors - adverse effects; Platelet Aggregation Inhibitors - therapeutic use; Risk; Risk Assessment